Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1969 1
1972 2
1973 3
1974 2
1975 1
1977 1
1979 2
1980 5
1981 2
1982 3
1983 3
1984 6
1985 5
1986 5
1987 5
1988 4
1989 5
1990 7
1991 11
1992 10
1993 12
1994 17
1995 21
1996 10
1997 12
1998 14
1999 17
2000 17
2001 21
2002 28
2003 15
2004 13
2005 15
2006 19
2007 14
2008 19
2009 25
2010 18
2011 13
2012 20
2013 20
2014 20
2015 39
2016 19
2017 29
2018 22
2019 14
2020 30
2021 30
2022 32
2023 26

Text availability

Article attribute

Article type

Publication date

Search Results

652 results

Results by year

Filters applied: . Clear all
Page 1
Mavacamten Treatment for Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ismayl M, Abbasi MA, Marar R, Geske JB, Gersh BJ, Anavekar NS. Ismayl M, et al. Curr Probl Cardiol. 2023 Jan;48(1):101429. doi: 10.1016/j.cpcardiol.2022.101429. Epub 2022 Sep 24. Curr Probl Cardiol. 2023. PMID: 36167226 Review.
Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy, yet pharmacological therapy has been unchanged for decades until the recent introduction of mavacamten, a first-in-class cardiac myosin inhibitor. We assessed the efficacy and safe …
Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy, yet pharmacological therapy has been unc …
Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies.
Walsh R, Offerhaus JA, Tadros R, Bezzina CR. Walsh R, et al. Nat Rev Cardiol. 2022 Mar;19(3):151-167. doi: 10.1038/s41569-021-00608-2. Epub 2021 Sep 15. Nat Rev Cardiol. 2022. PMID: 34526680 Review.
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian disease but is now increasingly recognized as having a complex genetic aetiology. ...Genes associated with Mendelian cardiomyopathy are enriched in the putative c …
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian disease but is now increasing …
Incidence and Etiology of Sudden Cardiac Death: New Updates for Athletic Departments.
Asif IM, Harmon KG. Asif IM, et al. Sports Health. 2017 May/Jun;9(3):268-279. doi: 10.1177/1941738117694153. Epub 2017 Feb 1. Sports Health. 2017. PMID: 28452637 Free PMC article. Review.
Initial reports suggest that the most common cause of SCD is hypertrophic cardiomyopathy (HCM). However, more comprehensive investigations in the United States and international populations-athletes, nonathletes, and military-support that the most common finding on …
Initial reports suggest that the most common cause of SCD is hypertrophic cardiomyopathy (HCM). However, more comprehensive in …
[Hypertrophic cardiomyopathy].
Batzner A, Seggewiß H. Batzner A, et al. Herz. 2020 May;45(3):233-242. doi: 10.1007/s00059-020-04899-y. Herz. 2020. PMID: 32185419 Review. German.
Hypertrophic cardiomyopathy is the most common genetically determined cardiac disease with a prevalence of 0.2-0.6%. ...
Hypertrophic cardiomyopathy is the most common genetically determined cardiac disease with a prevalence of 0.2-0.6%. ...
Hypertrophic cardiomyopathy: a review.
Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hensley N, et al. Anesth Analg. 2015 Mar;120(3):554-569. doi: 10.1213/ANE.0000000000000538. Anesth Analg. 2015. PMID: 25695573 Review.
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder that anesthesiologists encounter among patients in the perioperative period. ...Cardiac magnetic resonance imaging also has a diagnostic role by determining the extent and location of left ventricular …
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder that anesthesiologists encounter among patients in the perio …
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
Mascia G, Crotti L, Groppelli A, Canepa M, Merlo AC, Benenati S, Di Donna P, Della Bona R, Soranna D, Zambon A, Porto I, Olivotto I, Parati G, Brignole M, Cecchi F. Mascia G, et al. Int J Cardiol. 2022 Jun 15;357:88-94. doi: 10.1016/j.ijcard.2022.03.028. Epub 2022 Mar 15. Int J Cardiol. 2022. PMID: 35304190 Review.
AIMS: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the relevance of syncope as risk factor for sudden cardiac death and life-threatening arrhythmic events. ...Life-threatening arrhythmic events occ …
AIMS: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the re …
Genetics of feline hypertrophic cardiomyopathy.
Gil-Ortuño C, Sebastián-Marcos P, Sabater-Molina M, Nicolas-Rocamora E, Gimeno-Blanes JR, Fernández Del Palacio MJ. Gil-Ortuño C, et al. Clin Genet. 2020 Sep;98(3):203-214. doi: 10.1111/cge.13743. Epub 2020 Apr 1. Clin Genet. 2020. PMID: 32215921 Review.
Hypertrophic cardiomyopathy (HCM) is characterized by an abnormal increase in myocardial mass that affects cardiac structure and function. ...
Hypertrophic cardiomyopathy (HCM) is characterized by an abnormal increase in myocardial mass that affects cardiac structure a …
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Evidence-based Review About Mechanism, Complications and Management.
Arunachalam K, Maan A, Chu A. Arunachalam K, et al. Crit Pathw Cardiol. 2020 Jun;19(2):87-89. doi: 10.1097/HPC.0000000000000210. Crit Pathw Cardiol. 2020. PMID: 32011359 Review.
Hypertrophic cardiomyopathy (HCM) is 1 of the most frequent genetic cardiovascular diseases affecting 1 out of every 500 individuals in general population. Atrial Fibrillation incidences were 3.8% per 100 patients per year and overall prevalence among HCM pat …
Hypertrophic cardiomyopathy (HCM) is 1 of the most frequent genetic cardiovascular diseases affecting 1 out of every 500 indiv …
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.
Guttmann OP, Rahman MS, O'Mahony C, Anastasakis A, Elliott PM. Guttmann OP, et al. Heart. 2014 Mar;100(6):465-72. doi: 10.1136/heartjnl-2013-304276. Epub 2013 Sep 7. Heart. 2014. PMID: 24014282 Review.
OBJECTIVE: To critically review current literature on atrial fibrillation (AF) and thromboembolism in hypertrophic cardiomyopathy (HCM) and meta-analyse prevalence and incidence. ...Overall prevalence of thromboembolism in HCM patients with AF was 27.09% (95% CI 20. …
OBJECTIVE: To critically review current literature on atrial fibrillation (AF) and thromboembolism in hypertrophic cardiomyopathy …
Cardiac MRI of Hereditary Cardiomyopathy.
Fadl SA, Revels JW, Rezai Gharai L, Hanneman K, Dana F, Proffitt EK, Grizzard JD. Fadl SA, et al. Radiographics. 2022 May-Jun;42(3):625-643. doi: 10.1148/rg.210147. Epub 2022 Mar 11. Radiographics. 2022. PMID: 35275782 Review.
It clearly shows regions of asymmetric wall thickening that are typical of hypertrophic cardiomyopathy and allows it to be differentiated from other hereditary disorders such as Fabry disease or transthyretin cardiac amyloidosis that produce concentric hypertrophy. …
It clearly shows regions of asymmetric wall thickening that are typical of hypertrophic cardiomyopathy and allows it to be dif …
652 results